Cliquer ici pour toutes les publications du CNR-MyRMA en 2016
1368488
W4SXQV97
items
1
art-libraries-society-of-north-america-arlisna-reviews
0
default
asc
235
https://cnrmyrma.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-c26bfc0c64e806883376f170c49ec24f%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22W4SXQV97%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bernard%20et%20al.%22%2C%22parsedDate%22%3A%222016-09-07%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%26%23x201C%3BIn%20Vivo%20Mycobacterium%20Tuberculosis%20Fluoroquinolone%20Resistance%20Emergence%3A%20A%20Complex%20Phenomenon%20Poorly%20Detected%20by%20Current%20Diagnostic%20Tests%26%23x201D%3B%20by%20Christine%20Bernard%20et%20al.%20%3Ci%3EThe%20Journal%20of%20Antimicrobial%20Chemotherapy%3C%5C%2Fi%3E%2C%20September%207%2C%202016.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fjac%5C%2Fdkw344%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fjac%5C%2Fdkw344%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22In%20vivo%20Mycobacterium%20tuberculosis%20fluoroquinolone%20resistance%20emergence%3A%20a%20complex%20phenomenon%20poorly%20detected%20by%20current%20diagnostic%20tests%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aur%5Cu00e9lie%22%2C%22lastName%22%3A%22Chauffour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20Heteroresistance%2C%20described%20both%20in%20terms%20of%20various%20point%20mutations%20resulting%20in%20different%20levels%20of%20resistance%20and%20in%20terms%20of%20a%20mixture%20of%20mutant%20and%20WT%20bacilli%2C%20is%20identified%20in%20up%20to%20one-third%20of%20fluoroquinolone%20%28FQ%29-resistant%20Mycobacterium%20tuberculosis%20isolates.%20Heteroresistance%20is%20a%20challenge%20for%20current%20phenotypic%20and%20genotypic%20susceptibility%20testing%20%28DST%29%20regimes.%20We%20aimed%20to%20compare%20the%20performances%20of%20different%20phenotypic%20and%20genotypic%20DST%20in%20the%20context%20of%20FQ%20heteroresistance%20by%20mimicking%2C%20in%20a%20murine%20model%2C%20the%20course%20of%20selection%20of%20FQ%20resistance%20during%20treatment.%5CnMETHODS%3A%20The%20capacity%20of%20different%20phenotypic%20DST%20%5BLowenstein-Jensen%20%28LJ%29%20medium%20containing%20either%202%20mg%5C%2FL%20ofloxacin%20or%200.5%2C%201%20or%202%20mg%5C%2FL%20moxifloxacin%5D%20and%20genotypic%20DST%20%28gyrA%5C%2FB%20Sanger%20sequencing%29%20to%20detect%20FQ%20resistance%20was%20analysed.%5CnRESULTS%3A%20Ninety-seven%20percent%20of%20mice%20harboured%20a%20heterogeneous%20population.%20The%20proportion%20of%20mice%20in%20which%20FQ%20resistance%20was%20detected%20varied%20according%20to%20the%20medium%20used%20%2897%25%20for%200.5%20mg%5C%2FL%20moxifloxacin%2C%2080%25%20for%202%20mg%5C%2FL%20ofloxacin%2C%2047%25%20for%201%20mg%5C%2FL%20moxifloxacin%20and%2025%25%20for%202%20mg%5C%2FL%20moxifloxacin%29.%20Compared%20with%20phenotypic%20DST%2C%20genotypic%20DST%20had%20a%20low%20sensitivity%20for%20detection%20of%20resistance%20%2833%25%29.%5CnCONCLUSIONS%3A%20Our%20study%20shows%20the%20in%20vivo%20complexity%20of%20FQ%20resistance%20emergence%20and%20the%20poor%20sensitivity%20of%20Sanger%20DNA%20sequencing%20for%20detection%20of%20heteroresistance.%20Our%20data%20support%20the%20use%20of%200.5%20mg%5C%2FL%20moxifloxacin%20in%20LJ%20for%20detection%20of%20FQ%20resistance%2C%20but%20not%20the%20recent%20increase%20in%20the%20ofloxacin%20critical%20concentration%20from%202%20to%204%20mg%5C%2FL%20given%20in%20the%20WHO%20recommendations.%22%2C%22date%22%3A%22Sep%207%2C%202016%22%2C%22language%22%3A%22ENG%22%2C%22DOI%22%3A%2210.1093%5C%2Fjac%5C%2Fdkw344%22%2C%22ISSN%22%3A%221460-2091%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222017-01-08T18%3A02%3A04Z%22%7D%7D%5D%7D
“In Vivo Mycobacterium Tuberculosis Fluoroquinolone Resistance Emergence: A Complex Phenomenon Poorly Detected by Current Diagnostic Tests” by Christine Bernard et al. The Journal of Antimicrobial Chemotherapy, September 7, 2016. https://doi.org/10.1093/jac/dkw344.